{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:36:13Z","timestamp":1792791373100,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":299,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.jtauto.2021.100129","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T11:21:18Z","timestamp":1635420078000},"page":"100129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Autoimmune rheumatic diseases: One or many diseases?"],"prefix":"10.1016","volume":"4","author":[{"given":"Haralampos M.","family":"Moutsopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtauto.2021.100129_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/cei.13101","article-title":"Genetics of immune-mediated inflammatory diseases","author":"David","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jtauto.2021.100129_bib2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.micpath.2018.01.004","article-title":"Infections, genetic and environmental factors in pathogenesis of autoimmune thyroid diseases","volume":"116","author":"Shukla","year":"2018","journal-title":"Microb. Pathog."},{"issue":"1","key":"10.1016\/j.jtauto.2021.100129_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/ard.2007.084152","article-title":"Stress, coping strategies and social support in patients with primary Sj\u00f6gren's syndrome prior to disease onset: a retrospective case-control study","volume":"68","author":"Karaiskos","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2021.100129_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/1873-3468.12933","article-title":"How stress contributes to autoimmunity-lessons from Sj\u00f6gren\u2019s syndrome","volume":"592","author":"Skopouli","year":"2018","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.jtauto.2021.100129_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0090-1229(05)80001-7","article-title":"Cytokines and autoimmune disease","volume":"61","author":"Kroemer","year":"1991","journal-title":"Clin. Immunol. Immunopathol."},{"issue":"6","key":"10.1016\/j.jtauto.2021.100129_bib6","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1172\/JCI78088","article-title":"Mechanisms of human autoimmunity","volume":"125","author":"Rosenblum","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jtauto.2021.100129_bib7","series-title":"Skills in Rheumatology","article-title":"Classification criteria and clinical practice guidelines for rheumatic diseases","author":"Hassan","year":"2021"},{"issue":"1","key":"10.1016\/j.jtauto.2021.100129_bib8","first-page":"81","article-title":"Interferon and autoimmunity","volume":"1","author":"Moutsopoulos","year":"1983","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.jtauto.2021.100129_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12016-007-8042-1","article-title":"Sj\u00f6gren's syndrome or autoimmune epithelitis?","volume":"32","author":"Moutsopoulos","year":"2007","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jtauto.2021.100129_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.01.001","article-title":"Sj\u00f6gren's syndrome: a forty-year scientific journey","volume":"51","author":"Moutsopoulos","year":"2014","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.jtauto.2021.100129_bib11","first-page":"886","article-title":"Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic","volume":"25","author":"Vlachoyiannopoulos","year":"1998","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jtauto.2021.100129_bib12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13075-017-1266-4","article-title":"Poor prognostic factors guiding treatment decisions in rheumatoid arthritis patients: a review of data from randomized clinical trials and cohort studies","volume":"19","author":"Albrecht","year":"2017","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.jtauto.2021.100129_bib13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1523-1755.2000.00832.x","article-title":"Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide","volume":"57","author":"Ioannidis","year":"2000","journal-title":"Kidney Int."},{"issue":"25","key":"10.1016\/j.jtauto.2021.100129_bib14","article-title":"Predicting the risk for lymphoma development in Sjogren syndrome: an easy tool for clinical use","volume":"95","author":"Fragkioudaki","year":"2016","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jtauto.2021.100129_bib15","doi-asserted-by":"crossref","first-page":"102704","DOI":"10.1016\/j.jaut.2021.102704","article-title":"Interferon (IFN)-stimulated gene 15: a novel biomarker for lymphoma development in Sj\u00f6gren's syndrome","volume":"123","author":"Cinoku","year":"2021","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.jtauto.2021.100129_bib16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1183\/09031936.00110109","article-title":"Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis","volume":"36","author":"Tzelepis","year":"2010","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.jtauto.2021.100129_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","article-title":"Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)","volume":"52","author":"Sharp","year":"1972","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.jtauto.2021.100129_bib18","first-page":"363","volume":"12","author":"Iaccarino","year":"2013","journal-title":"Overlap connective tissue disease syndromes. Autoimmunity Reviews"},{"key":"10.1016\/j.jtauto.2021.100129_bib19","doi-asserted-by":"crossref","first-page":"R22","DOI":"10.1186\/ar2614","article-title":"Antibodies against PM\/Scl-75 and PM\/Scl-100 are independent markers for different subsets of systemic sclerosis patients","volume":"11","author":"Hanke","year":"2009","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.jtauto.2021.100129_bib20","first-page":"1098","article-title":"Secondary Sj\u00f6gren's syndrome in rheumatoid arthritis","volume":"14","author":"Andonopoulos","year":"1987","journal-title":"J. Rheumatol."},{"issue":"5","key":"10.1016\/j.jtauto.2021.100129_bib21","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0002-9343(79)91110-0","article-title":"Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis","volume":"66","author":"Moutsopoulos","year":"1979","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.jtauto.2021.100129_bib22","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/art.20093","article-title":"Sj\u00f6gren\u2019s syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sj\u00f6gren\u2019s syndrome","volume":"50","author":"Manoussakis","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.jtauto.2021.100129_bib23","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00296-005-0084-1","article-title":"A case of overlap syndrome with rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis and secondary Sj\u00f6gren's syndrome","volume":"26","author":"Turkcapar","year":"2006","journal-title":"Rheumatol. Int."},{"issue":"4","key":"10.1016\/j.jtauto.2021.100129_bib24","first-page":"149","article-title":"Evolution of one systemic rheumatic disease into another: scleroderma evolving to eosinophilic fasciitis with myositis","volume":"37","author":"Zampeli","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"issue":"4","key":"10.1016\/j.jtauto.2021.100129_bib25","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.semarthrit.2017.06.007","article-title":"Concordance of autoimmune disease in a nationwide Danish systemic lupus erythematosus twin cohort","volume":"47","author":"Ulff-M\u00f8ller","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2021.100129_bib26","series-title":"Immunology and Rheumatology in Questions","first-page":"35","article-title":"Autoimmune rheumatic disorders: pathogenetic and laboratory aspects","author":"Pers","year":"2021"},{"issue":"11","key":"10.1016\/j.jtauto.2021.100129_bib27","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/art.39795","article-title":"Crow MK expression of long interspersed nuclear element 1 retroelements and induction of type I interferon in patients with systemic autoimmune disease","volume":"68","author":"Mavragani","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2021.100129_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaut.2017.10.004","article-title":"Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: role of methylating enzymes","volume":"88","author":"Mavragani","year":"2018","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.jtauto.2021.100129_bib29","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/rheumatology\/37.6.691","article-title":"Prevalence of Sj\u00f6gren's-like syndrome in a cohort of HIV-1-positive patients: descriptive pathology and immunopathology","volume":"37","author":"Kordossis","year":"1998","journal-title":"Br. J. Rheumatol."},{"issue":"3","key":"10.1016\/j.jtauto.2021.100129_bib30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.7326\/0003-4819-130-3-199902020-00027","article-title":"Mixed cryoglobulinemia in HIV-1 infection: the role of HIV-1","volume":"130","author":"Dimitrakopoulos","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jtauto.2021.100129_bib31","series-title":"The Clinical Spectrum of diseaseHepatology","first-page":"155","author":"Hoofnagle","year":"2003"},{"key":"10.1016\/j.jtauto.2021.100129_bib32","doi-asserted-by":"crossref","first-page":"102506","DOI":"10.1016\/j.jaut.2020.102506","article-title":"Autoinflammatory and autoimmune conditions at the crossroad of COVID-19","volume":"114","author":"Rodr\u00edguez","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jtauto.2021.100129_bib33","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1212\/WNL.0000000000002218","article-title":"Herpes simplex virus 1 encephalitis associated with voltage-gated calcium channel autoimmunity","volume":"85","author":"Bradshaw","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jtauto.2021.100129_bib34","article-title":"Autoimmune hepatitis following Epstein\u2013Barr virus infection","volume":"2008","author":"Cabibi","year":"2008","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.jtauto.2021.100129_bib35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ymeth.2006.07.009","article-title":"Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity","volume":"41","author":"Fairweather","year":"2007","journal-title":"Methods"},{"issue":"9","key":"10.1016\/j.jtauto.2021.100129_bib36","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1002\/art.20463","article-title":"Evidence for coxsackievirus infection in primary Sj\u00f6gren's syndrome","volume":"50","author":"Triantafyllopoulou","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2021.100129_bib37","author":"Karagianni","year":"2019","journal-title":"West Nile Virus infection triggering autoimmune encephalitis: Pathophysiological and therapeutic implications. Clinical Immunology"},{"key":"10.1016\/j.jtauto.2021.100129_bib38","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3389\/fmicb.2017.01392","article-title":"Microbes and viruses are bugging the gut in celiac disease. Are they friends or foes?","volume":"8","author":"Lerner","year":"2017","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.jtauto.2021.100129_bib39","first-page":"134","article-title":"Anti-Ro52 and\/or anti-Ro60 immune reactivity: autoantibody and disease associations","volume":"38","author":"Zampeli","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jtauto.2021.100129_bib40","series-title":"Immunology and Rheumatology in Questions","first-page":"38","article-title":"Autoimmune rheumatic disorders: pathogenetic and laboratory aspects","author":"Pers","year":"2021"},{"issue":"16","key":"10.1016\/j.jtauto.2021.100129_bib41","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jtauto.2021.100129_bib42","first-page":"9259646","article-title":"Biologics for targeting inflammatory cytokines, clinical uses, and limitations","volume":"2016","author":"Rider","year":"2016","journal-title":"IntJ Cell Biol"},{"key":"10.1016\/j.jtauto.2021.100129_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2016.12.011","article-title":"A comprehensive evaluation for the treatment of lupus nephritis","volume":"78","author":"Zampeli","year":"2017","journal-title":"J. Autoimmun."}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909021000496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909021000496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:39:37Z","timestamp":1762904377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909021000496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":43,"alternative-id":["S2589909021000496"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2021.100129","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune rheumatic diseases: One or many diseases?","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2021.100129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100129"}}